Rossari Biotech Ltd Q1FY24 consolidated PAT up at Rs. 29.21 crores

Rossari Biotech Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 412.796 crores during the period ended June 30, 2023 as compared to Rs. 409.272 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 29.219 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 28.979 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 5.28 for the period ended June 30, 2023 as compared to Rs. 5.24 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 412.796 crs	₹409.272 crs	0.86%
Net Profit	₹29.219 crs	₹28.979 crs	0.83%
EPS	₹5.28	₹5.24	0.76%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 412.796 crores during the period ended June 30, 2023 as compared to Rs.435.454 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.29.219 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.28.680 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.5.28 for the period ended June 30, 2023 as compared to Rs.5.18 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 412.796 crs	₹435.454 crs	-5.20%
Net Profit	₹29.219 crs	₹28.680 crs	1.88%
EPS	₹5.28	₹5.18	1.93%

Shares of Rossari Biotech Limited was last trading in BSE at Rs. 875.50 as compared to the previous close of Rs. 881.45. The total number of shares traded during the day was 5278 in over 354 trades.

The stock hit an intraday high of Rs. 888.90 and intraday low of 870.65. The net turnover during the day was Rs. 4618600.00.

Source : Equity Bulls

Keywords

RossariBiotech Q1FY24 ResultUpdate